Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.315 +0.065 (+2.00%)
Streaming Delayed Price Updated: 12:43 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 Next >
Maravai LifeSciences (MRVI) Stock Plummets After Q3 2025 Revenue Miss and Weak Guidance
Maravai LifeSciences (MRVI) stock fell after Q3 2025 revenue missed estimates. The company reported a net loss and provided full-year guidance below analyst expectations. 
Via Chartmill
Earnings Scheduled For November 6, 2025
 
Via Benzinga
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings.... 
Via MarketMinute
Topics Economy Stocks
What to Expect from Maravai LifeSciences's Earnings
 
Via Benzinga
Earnings Scheduled For May 12, 2025
 
Via Benzinga
Insights Ahead: Maravai LifeSciences's Quarterly Earnings
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
4 Analysts Have This To Say About Maravai LifeSciences
 
Via Benzinga
Earnings Scheduled For August 11, 2025
 
Via Benzinga
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results
 
Via Benzinga
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts
 
Via Benzinga
Breaking Down Maravai LifeSciences: 4 Analysts Share Their Views
 
Via Benzinga
Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Topics Government
Maravai LifeSciences (MRVI) Q4 2024 Earnings Call Transcript
MRVI earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Decoding 5 Analyst Evaluations For Maravai LifeSciences
 
Via Benzinga
Maravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
 
Via Benzinga
Unveiling 4 Analyst Insights On Maravai LifeSciences
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
3 Struggling Stocks Down More Than 50% This Year That Look Cheap But Come With Plenty of Risk
Via The Motley Fool
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
 
Via Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
MRVI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Wall Street Ticks Up As Consumer Sentiment Improves; Gold Hits Record Highs, Boosting Mining Stocks: What's Driving Markets Friday?
Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York. 
Via Benzinga
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript
MRVI earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.